The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Notice of AGM Explanatory Notes

17 Jun 2022 16:58

RNS Number : 3697P
Pathfinder Minerals Plc
17 June 2022
 

17 June 2022

 

Pathfinder Minerals Plc

("Pathfinder" or the "Company")

 

Notice of AGM Explanatory Notes

 

Further to the announcement of 6 June 2022 notifying shareholders of the posting of a notice convening an annual general meeting (the "Notice"), Pathfinder wishes to notify shareholders that the explanatory notes in paragraph 2 of the letter from the chairman which accompanied the Notice contained a typographical error. The explanatory notes should have stated:

 

· Resolution 4 - Reappointment of Director

To reappoint as a director, Mark Richard Gasson

 

· Resolution 5 - Reappointment of Director

To reappoint as a director, Jonathan William Summers

 

The resolutions were correctly stated both within the Notice itself and the proxy form.

 

Enquiries:

 

Pathfinder Minerals Plc

Peter Taylor, Chief Executive Officer

Tel. +44 (0)20 3143 6748

 

Strand Hanson Limited (Nominated & Financial Adviser and Broker)

James Spinney / Ritchie Balmer / Rob Patrick

Tel. +44 (0)20 7409 3494

 

Vigo Consulting (Public Relations)

Ben Simons / Charlie Neish / Kate Kilgallen

Tel. +44 (0)20 7390 0234

Email. pathfinderminerals@vigoconsulting.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOAFRMATMTABBRT

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.